The ability of GRP78 to regulate breast cancer cell survival was also cell surface dependent, since inhibiting cell surface function of GRP78 with the inhibitory antibody to GRP78 resulted in a higher susceptibility to cisplatin treatment (Fig. 2G). The gene discussed is HSPA5; the disease is breast carcinoma.